48,830
edits
m (→Neuropathology: w) |
m (→Utility) |
||
Line 6: | Line 6: | ||
#Poorly differentiated tumours. | #Poorly differentiated tumours. | ||
#Prognostic markers, e.g. ERBB2 (HER2). | #Prognostic markers, e.g. ERBB2 (HER2). | ||
#Proving clonality - in the context of hematologic malignancies. | |||
==General (malignant) differential diagnosis== | ==General (malignant) differential diagnosis== |
edits